Literature DB >> 7715981

Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy commission.

U B Schaad1, M abdus Salam, Y Aujard, R Dagan, S D Green, H Peltola, T T Rubio, A L Smith, D Adam.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7715981     DOI： 10.1097/00006454-199501000-00001

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  17 in total

Review 1.  Tolerability of fluoroquinolone antibiotics. Past, present and future.

Authors:  P Ball; G Tillotson
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

2.  A reappraisal of quinolone tolerability. The experience of their musculoskeletal adverse effects.

Authors:  G Hayem; C Carbon
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

3.  The place of quinolones in paediatric anti-infective therapy.

Authors:  J Langley
Journal:  Paediatr Child Health       Date:  2001-07       Impact factor: 2.253

Review 4.  Joint disorders in cystic fibrosis.

Authors:  M A Turner; E Baildam; L Patel; T J David
Journal:  J R Soc Med       Date:  1997       Impact factor: 5.344

5.  Pharmacokinetics of oral and intravenous ofloxacin in children with multidrug-resistant typhoid fever.

Authors:  D B Bethell; N P Day; N M Dung; C McMullin; H T Loan; D T Tam; L T Minh; N T Linh; N Q Dung; H Vinh; A P MacGowan; L O White; N J White
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

6.  Pharmacokinetics of ciprofloxacin in pediatric cystic fibrosis patients.

Authors:  H G Schaefer; H Stass; J Wedgwood; B Hampel; C Fischer; J Kuhlmann; U B Schaad
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

Review 7.  Fluoroquinolones in paediatrics.

Authors:  D Gendrel; F Moulin
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 8.  Quinolone use in the developing world: state of the art.

Authors:  T E Tupasi
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 9.  Comparative tolerability of the newer fluoroquinolone antibacterials.

Authors:  P Ball; L Mandell; Y Niki; G Tillotson
Journal:  Drug Saf       Date:  1999-11       Impact factor: 5.606

10.  Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins.

Authors:  M B Klein; C M Nelson; J L Goodman
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.